Hemogenyx Pharmaceuticals PLC Announces Presentation at CBD S&T Conference

The Company competed for a presentation slot and was invited to present its work on its proprietary Chimeric Bait Receptor (“CBR”) platform for combating viral infections. The presentation is entitled …